How are animal viruses used in vaccine development?

• A. They are used as a source of antibiotics
• B. They are engineered to produce toxins
• C. They are modified to carry a gene for another microbe's surface protein
• D. They are used to culture bacteria in research

Answer: (C)

Animal viruses play a pivotal role in vaccine development through a process that often involves genetic engineering to enhance their utility as vectors. The correct option highlights that these viruses can be modified to carry genes encoding surface proteins from other pathogens, such as bacteria or viruses. This approach allows the immune system to recognize and respond to the foreign proteins, leading to the production of antibodies without causing disease.

By delivering a gene that encodes a protective antigen (such as a surface protein of a virus), the modified virus can stimulate an immune response. This can create a form of immune memory, enabling the body to mount a robust defense if it encounters the actual pathogen in the future. This method is often used in the development of vaccines against diseases such as influenza, hepatitis, and more recently, in some COVID-19 vaccine technologies.

The other options explore concepts that are not directly related to the typical mechanisms of vaccine development using animal viruses. For instance, using viruses as a source of antibiotics or for culturing bacteria does not align with the immunological strategy of inducing an immune response through vaccination. Additionally, engineering viruses to produce toxins would potentially create harmful outcomes rather than a protective immunological response necessary for effective vaccination.